Geneplus-beijing Co. Ltd.
Clinical trials sponsored by Geneplus-beijing Co. Ltd., explained in plain language.
-
New study aims to predict immunotherapy response in lung cancer patients before surgery
Knowledge-focused Recruiting nowThis study is looking for genetic clues that might tell doctors whether immunotherapy will work well before lung cancer surgery. Researchers will collect blood and tumor samples from 100 people with stage II-IIIB non-small cell lung cancer. They will test for two types of genetic…
Sponsor: Geneplus-Beijing Co. Ltd. • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Blood test may replace scans for some colorectal cancer patients on immunotherapy
Knowledge-focused Recruiting nowThis study is looking at whether a simple blood test that tracks tumor DNA (ctDNA) can better predict how well immunotherapy is working in people with advanced colorectal cancer. Currently, doctors rely on imaging scans, which can miss cases where the cancer is actually gone. The…
Sponsor: Geneplus-Beijing Co. Ltd. • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC